K&L Gates Health Care Triage
By K&L Gates
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by K&L Gates
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 100
Description
Triage: Rapid Legal Lessons for Busy Health Care Professionals has been created by K&L Gates to convey information about developments in health law through short podcasts. If you work in the health care industry, you have grown accustomed to frequent changes in laws and regulations. On some days, it may seem like an insurmountable task to keep up with every change, especially as a new presidential administration and new policies take shape. The K&L Gates Health Care practice will regularly create Triage podcasts to help you learn about the latest developments in health law. Our lawyers will identify the most important changes and analyze the impact of these changes on our clients.
| Episode | Date |
|---|---|
|
Corporate Practice of Medicine: New Relevance in a Changing World
|
Apr 09, 2024 |
|
Health System Cybersecurity Risks: Part Two
|
Apr 01, 2024 |
|
Health System Cybersecurity Risks: Part One
|
Mar 26, 2024 |
|
Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast
|
Mar 05, 2024 |
|
FDA Issues Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors
|
Oct 12, 2023 |
|
Ensuring Continuity of Care Following a Cyberattack: ARPA-H Launches Project to Enhance Cybersecurity Tools for Health Care Organizations
|
Sep 08, 2023 |
|
Unpacking CMS's Proposed Rule for Correcting Underpayments for 340B Drug Reimbursement
|
Aug 22, 2023 |
|
The End of Continuous Medicaid Enrollment—What Health Systems Should Know
|
Jul 12, 2023 |
|
Value-Based Lessons Learned: Two Years Later, How Have Providers Utilized New AKS and Stark Flexibilities?
|
Jun 27, 2023 |
|
Highlights for Research Institutions and Sponsors in FDA's Recent Draft Guidance on Decentralized Clinical Trials
|
Jun 01, 2023 |
|
2022 Health Care Employment Law Year in Review
|
Mar 29, 2023 |
|
Rural Emergency Hospitals — Transformative Change or Limited Impact?
|
Mar 21, 2023 |
|
Stark Law and the Anti-Kickback Statute Under the False Claims Act
|
Jan 12, 2023 |
|
Stark Law and the Anti-Kickback Statue Under the False Claims Act
|
Jan 12, 2023 |
|
Recent Developments to the 340B Drug Pricing Program
|
Dec 15, 2022 |
|
The Information Blocking Rule's "Glide Path" - Compliance with the Information Blocking Rule After the Limitation on the Scope of EHI is Lifted
|
Nov 29, 2022 |
|
New Data Available Under the Hospital Price Transparency Rule
|
Nov 14, 2022 |
|
Issue-Spotting Hospital Activities that May Trigger FDA Regulatory Oversight
|
Sep 26, 2022 |
|
Cybersecurity & HIPAA: NIST’s Practical Guidance Updates for Covered Entities and Business Associates
|
Aug 29, 2022 |
|
Genesis Healthcare and the 340B Program Patient Definition
|
Aug 09, 2022 |
|
Medicare Advantage False Claims Act Developments
|
Aug 02, 2022 |
|
Hospitals, Physician Practices, and Labs – Are You Ready to Report Private Payor Rates for Laboratory Tests?
|
Jul 05, 2022 |
|
The Drive to Align ESG and Health Equity Priorities With Medicare Reimbursement Models
|
Jun 07, 2022 |
|
Regulatory, Contractual, and Governance Considerations for Data Transactions
|
May 10, 2022 |
|
Medical Laboratories Under the Microscope
|
Apr 22, 2022 |
|
Navigating the Independent Dispute Resolution Process Under the No Surprises Act
|
Mar 30, 2022 |
|
2021 Health Care Employment Law Year in Review and a Look Forward
|
Mar 23, 2022 |
|
Medicare Reimbursement for Community Hospital Residency Programs
|
Jan 31, 2022 |
|
Data Security Breaches in the Health Care Sector
|
Jan 20, 2022 |
|
What Health Care Providers Should Expect in an FDA Inspection
|
Oct 28, 2021 |
|
An Update on the CMS Hospital Price Transparency Rule
|
Oct 21, 2021 |
|
FTC Reminds Vendors of Personal Health Records of Breach Rule Obligations
|
Oct 07, 2021 |
|
No Surprises: New Balance Billing Regulations for Health Care Providers
|
Sep 16, 2021 |
|
CMS’s Proposal for New Remote Therapeutic Monitoring Codes under the 2022 Medicare Physician Fee Schedule
|
Aug 19, 2021 |
|
Key Considerations for Officers and Directors of Distressed Companies
|
Aug 17, 2021 |
|
Cybersecurity Risk in the Health Care Industry
|
Aug 09, 2021 |
|
When Regulatory Review is Necessary: Clinical Research vs. Quality Initiatives
|
Jul 15, 2021 |
|
OFCCP Enforcement in the Health Care Space
|
Jul 08, 2021 |
|
Understanding OIG and CMS Audits
|
Jun 10, 2021 |
|
The Power of Health Care: Renewable Energy Transactions from the Health Care Perspective
|
Jun 03, 2021 |
|
Health Care Audit and Reimbursement Trends and Challenges
|
Apr 29, 2021 |
|
Long-Term Care: Exploring Lessons from the Past Year and Current Topics Facing the Industry
|
Apr 22, 2021 |
|
Health Care Transactions Trends in 2021 and Beyond
|
Apr 08, 2021 |
|
340B Drug Pricing Program 2021 Outlook
|
Mar 19, 2021 |
|
Health Care and Employment Law: 2020 Year in Review and Looking Ahead
|
Mar 15, 2021 |
|
What to Expect in Health Care in 2021
|
Feb 26, 2021 |
|
What AMCs May Expect in Health Care Policy Priorities from the New Congress and the Biden Administration
|
Feb 18, 2021 |
|
Information Blocking Considerations for Providers Under the CMS Interoperability and Patient Access Final Rule
|
Dec 17, 2020 |
|
Recent District Court Decision Highlights the Importance of Adequate Behavioral Health Claims Processing Guidelines for ERISA Plans
|
Dec 11, 2020 |
|
340B Update: HRSA Moves Forward with 340B ADR Rule as Covered Entities Challenge Contract Pharmacy Actions
|
Dec 03, 2020 |
|
COVID-19: Frontline University Perspective on the Pandemic’s Disruption to Ongoing Research, and Public Policy Projections for a Federal Response
|
Nov 23, 2020 |
|
COVID-19: CARES Act Provider Relief Fund Compliance and Potential FCA Enforcement
|
Nov 20, 2020 |
|
COVID-19: FDA Warning Letters Address Fraudulent Products and Failures to Meet EUA Requirements
|
Nov 12, 2020 |
|
COVID-19: Finding Sources of Reimbursement Relief for Providers During COVID-19
|
Nov 03, 2020 |
|
K&L Gates Triage: Eye on Election 2020: California v. Texas and the Future of the Affordable Care Act
|
Oct 29, 2020 |
|
K&L Gates Triage: CMS Cease and Desist Letters to COVID Labs and Reimbursement Dispute
|
Oct 23, 2020 |
|
K&L Gates Triage: COVID-19: State and Federal Developments in the Regulation of Long-Term Care Facilities
|
Oct 21, 2020 |
|
K&L Gates Triage: ACO Quality Reporting in 2021: Key Changes from the Medicare Physician Fee Schedule Proposed Rule
|
Oct 08, 2020 |
|
K&L Gates Triage: The Preventing Harm Exception to the ONC Information Blocking Rule
|
Oct 02, 2020 |
|
K&L Gates Triage: Updates to Mental Health Parity in California and Nationwide
|
Sep 28, 2020 |
|
COVID-19: K&L Gates Triage: OIG Updates Work Plan to Include Audits of COVID-19 Related Reimbursement and CARES Act Funding
|
Sep 18, 2020 |
|
K&L Gates Triage: Rutledge v. Pharmaceutical Care Management Association
|
Sep 10, 2020 |
|
COVID-19: K&L Gates Triage: COVID-19 and Social Determinants of Health -- A Closer Look at the Disparate Impact of COVID-19 on Ethnic and Racial Minorities
|
Sep 04, 2020 |
|
K&L Gates Triage: Q&A: What Sponsors and Investigators Need to Know about FDA’s ClinicalTrials.gov Reporting Requirements
|
Aug 27, 2020 |
|
K&L Gates Triage: HIPAA: Do Hospitals Need a Business Associate Agreement with their Health System Parent Corporation?
|
Aug 20, 2020 |
|
340B Update: Appellate Court Upholds 340B Payment Reduction as CMS Proposes Further Reductions for 2021
|
Aug 13, 2020 |
|
Michael P. v. BCBS of Texas
|
Aug 05, 2020 |
|
K&L Gates Triage: Recent Developments in the 340B Drug Pricing Program
|
Jul 23, 2020 |
|
COVID-19: K&L Gates Triage: COVID Audits
|
Jul 17, 2020 |
|
COVID-19: K&L Gates Triage: Alternative Payment Models: Tied to an Improved COVID-19 Response?
|
Jul 01, 2020 |
|
COVID-19: K&L Gates Triage: United States vs Australia-Future of Nursing Homes and Long Term Care Facilities and What it Will Take to Succeed
|
Jun 25, 2020 |
|
COVID-19: K&L Gates Triage: Community Health Center Response to COVID-19 and the Evolving Landscape of Delivery of Care
|
Jun 22, 2020 |
|
COVID-19: K&L Gates Triage: Nursing Homes and Long Term Care Facilities in the COVID-19 Environment: Huge Disparity between United States and Australia
|
Jun 11, 2020 |
|
COVID-19: K&L Gates Triage: Responding to the Unimaginable: Legal Challenges for Nursing Homes & Long-Term Care Facilities in a COVID-19 Enforcement Environment
|
Jun 09, 2020 |
|
COVID-19: K&L Gates Triage: Considerations for Behavioral Health Providers in the COVID-19 Environment and Beyond
|
Jun 04, 2020 |
|
COVID-19: K&L Gates Triage: Workplace Safety Highlights from the CDC’s May 2020 “Ten Ways Healthcare Systems Can Operate Effectively During the COVID-19 Pandemic” Guidance
|
May 28, 2020 |
|
COVID-19: K&L Gates Triage: Telehealth Expansions During the COVID-19 Emergency - What Providers Need to Know
|
May 21, 2020 |
|
COVID-19: K&L Gates Triage: Value-Based Payment Arrangements
|
May 07, 2020 |
|
COVID-19: 340B Update - Hospitals Request Eligibility Flexibilities Amid COVID-19 Pandemic
|
Apr 09, 2020 |
|
COVID-19: K&L Gates Triage: COVID-19 Stark Waivers
|
Apr 02, 2020 |
|
COVID-19: K&L Gates Triage: FDA Facilitates Diagnostic Testing and Heightens Public Safety Efforts Amid Outbreak
|
Mar 26, 2020 |
|
K&L Gates Triage: COVID-19 - HIPAA Concerns in the Context of Novel Coronavirus
|
Mar 09, 2020 |
|
K&L Gates Triage: Health Care Provider v. Payor Disputes Simplified: Getting Around ERISA Preemption
|
Mar 05, 2020 |
|
K&L Gates Triage: The Impact of Allina — Potential Limitation on CMS’s Ability to Recoup Overpayments
|
Feb 27, 2020 |
|
K&L Gates Triage: EKRA - New Fraud and Abuse Considerations for Clinically Integrated Networks
|
Feb 20, 2020 |
|
K&L Gates Triage: ONC Signals Federal Health IT Priorities with 2020-2025 Strategic Plan
|
Feb 13, 2020 |
|
K&L Gates Triage: 340B Update: CMS Issues Guidance for Avoiding Duplicate Discounts in Medicaid
|
Jan 30, 2020 |
|
Triage in 2020: Health Care Topics to Watch in the New Year
|
Jan 23, 2020 |
|
K&L Gates Triage: Looking Ahead to 2020: Developing Issues in Pharmacy Law and the 340B Drug Pricing Program
|
Dec 19, 2019 |
|
K&L Gates Triage: IPPS-Excluded Hospitals May Now Have IPPS-Excluded Units
|
Oct 25, 2019 |
|
K&L Gates Triage: Quality Payment Program Updates in the CY2020 Physician Fee Schedule Proposed Rule - Part 3
|
Oct 17, 2019 |
|
K&L Gates Triage: Modernizing Confidentiality Rules for Substance Use Disorder Records (Again): 2019 Proposed Changes to 42 CFR Part 2 - Part 2
|
Oct 16, 2019 |
|
K&L Gates Triage: The Opioid Epidemic & the Confidentiality of Substance Use Disorder Records: an Update on 42 CFR Part 2 - Part 1 of 2
|
Oct 08, 2019 |
|
K&L Gates Triage: Quality Payment Program Updates in the CY2020 Physician Fee Schedule Proposed Rule - Part 2
|
Oct 04, 2019 |
|
K&L Gates Triage: Quality Payment Program Updates in the CY2020 Physician Fee Schedule Proposed Rule - Part 1
|
Sep 26, 2019 |
|
K&L Gates Triage: Five Key Questions for Academic Medical Centers About Patent Ownership and Enforcement
|
Sep 18, 2019 |
|
K&L Gates Triage: Recent Developments Impacting Drug Pricing and the 340B Program: Part 2
|
Sep 11, 2019 |
|
K&L Gates Triage: Recent Developments Impacting Drug Pricing and the 340B Program: Part 1
|
Sep 06, 2019 |
|
K&L Gates Triage: Activation of Validation Edits for OPPS Providers with Multiple Service Locations
|
Aug 29, 2019 |
|
K&L Gates Triage: Recent Developments in Provider v. Payer Litigation - Encompass v. Blue Cross
|
Jun 27, 2019 |